Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Feb 14.
doi: 10.1007/s10578-023-01658-y. Online ahead of print.

Obsessive-Compulsive Symptoms: Baseline Prevalence, Comorbidity, and Implications in a Clinically Anxious Pediatric Sample

Affiliations

Obsessive-Compulsive Symptoms: Baseline Prevalence, Comorbidity, and Implications in a Clinically Anxious Pediatric Sample

Meryl Rueppel et al. Child Psychiatry Hum Dev. .

Abstract

Subclinical symptoms of obsessive-compulsive disorder (i.e., obsessive compulsive symptoms, or "OCS") cause functional impairment, including for youth without full-syndrome OCD. Further, despite high rates of OCS in youth with anxiety disorders, knowledge of OCS in the context of specific anxiety disorders is limited. The present study seeks to: (1) compare OCS in pediatric patients with anxiety disorders and healthy youth, (2) determine which categorical anxiety disorder(s) associate most with OCS, and (3) determine relationships between OCS with anxiety severity and impairment. Data on OCS, anxiety, and functional impairment were collected from 153 youth with anxiety disorders and 45 healthy controls, ages 7-17 years (M = 11.84, SD = 3.17). Findings indicated that patients had significantly more OCS than healthy controls. Among patients, GAD was a significant predictor of OCS as well as OCD risk. These results suggest that OCS should be a primary diagnostic and treatment consideration for youth who present in clinical settings with GAD.

Keywords: Anxiety; Obsessive–compulsive symptoms; Pediatric; Psychopathology; Screening.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Abramowitz JS, Foa EB (1998) Worries and obsessions in individuals with obsessive–compulsive disorder with and without comorbid generalized anxiety disorder. Behav Res Ther 36(7–8):695–700. https://doi.org/10.1016/S0005-7967(98)00058-8 - DOI - PubMed
    1. Abramowitz JS, Deacon BJ (2006) Psychometric properties and construct validity of the obsessive-compulsive inventory–revised: replication and extension with a clinical sample. J Anxiety Disord 20(8):1016–1035. https://doi.org/10.1016/j.janxdis.2006.03.001 - DOI - PubMed
    1. Abramowitz JS, Deacon BJ, Olatunji BO, Wheaton MG, Berman NC, Losardo D, Timpano KR, Mcgrath PB, Riemann BC, Adams T, Storch EA, Hale LR (2010) Assessment of obsessive-compulsive symptom dimensions: development and evaluation of the dimensional obsessive-compulsive scale. Psychol Assess 22(1):180–198. https://doi.org/10.1037/a0018260 - DOI - PubMed
    1. Abramowitz J, Jacoby R (2014) The use and misuse of exposure therapy for obsessive-compulsive and related disorders. Curr Psychiatry Rev 10(4):277–283. https://doi.org/10.2174/1573400510666140714171934 - DOI
    1. Achenbach TM (1999) The child behavior checklist and related instruments. The use of psychological testing for treatment planning and outcomes assessment, 2nd edn. Lawrence Erlbaum Associates Publishers, pp 429–466

LinkOut - more resources